DRUG COMPANIES SEEK DISMISSAL OF SHAREHOLDER MERGER CHALLENGE In re Salix Pharms. Stockholder Litig. | Secondary Sources | Westlaw

DRUG COMPANIES SEEK DISMISSAL OF SHAREHOLDER MERGER CHALLENGE In re Salix Pharms. Stockholder Litig. | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, DRUG COMPANIES SEEK DISMISSAL OF SHAREHOLDER MERGER CHALLENGE In re Salix Pharms. Stockholder Litig., Secondary Sources
25 No. 10 Westlaw Journal Mergers & Acquisitions 6
Westlaw Journal Mergers & Acquisitions
*1 APRIL 17, 2015
Breach of Duty
Copyright © 2015 Thomson Reuters .

DRUG COMPANIES SEEK DISMISSAL OF SHAREHOLDER MERGER CHALLENGE

In re Salix Pharms. Stockholder Litig.

Briefs and Other Related Documents
After dissident shareholders of Salix Pharmaceuticals Ltd. abruptly dropped their bid for a preliminary injunction of a $14.5 billion sale to Valeant Pharmaceuticals International, the companies have asked the Delaware Chancery Court to dismiss the...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.